Pakistan Health News API

{
    "totalArticles": 63062,
    "articles": [
        {
            "id": "42c0fc1e9bdb1e1bef67bbb98cbc7a11",
            "title": "Diabetes - a growing health crisis in Pakistan",
            "description": "Type 2 diabetes, commonly known as “sugar” in Pakistan, has quietly become one of the most serious public health...",
            "content": "Type 2 diabetes, commonly known as “sugar” in Pakistan, has quietly become one of the most serious public health emergencies in the country. Almost every family is affected with this problem including parents, khala, phupo, chacha and some very young... [5691 chars]",
            "url": "https://www.brecorder.com/news/40408567/diabetes-a-growing-health-crisis-in-pakistan",
            "image": "https://i.brecorder.com/large/2026/02/231241151296a73.webp",
            "publishedAt": "2026-02-23T07:41:58Z",
            "lang": "en",
            "source": {
                "id": "afe8a257a88cf3405af1c3c278354490",
                "name": "Business Recorder",
                "url": "https://www.brecorder.com"
            }
        },
        {
            "id": "3ae4134d1a4594b708e2380095f2e762",
            "title": "Opterion Health AG Announces First Patient enrolled in",
            "description": "MUTTENZ, Switzerland, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Opterion Health AG today announced that the first patient has been successfully enrolled in its...",
            "content": "MUTTENZ, Switzerland, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Opterion Health AG today announced that the first patient has been successfully enrolled in its Phase 1 SPARC trial. This marks the official start of the company’s first-in-human clinical develo... [2377 chars]",
            "url": "https://www.globenewswire.com/news-release/2026/02/23/3242320/0/en/Opterion-Health-AG-Announces-First-Patient-enrolled-in-Phase-1-SPARC-Trial-Following-CTA-Approval-for-OPT101.html",
            "image": "https://ml-eu.globenewswire.com/Resource/Download/3147f7f2-a7b1-4bee-8ed8-401fd9c33ccb",
            "publishedAt": "2026-02-23T07:00:00Z",
            "lang": "en",
            "source": {
                "id": "e3491c58e9ff97f5db9f0984d1e2db51",
                "name": "GlobeNewswire",
                "url": "https://www.globenewswire.com"
            }
        },
        {
            "id": "6c4d2c08c6181733255beea1b2fe0100",
            "title": "Effect of breathing exercises on depression, sexual function, and exercise capacity in postmenopausal women: a randomized controlled trial",
            "description": "This trial aimed to explore the effect of supervised breathing exercises (BEs) on depression, sexual function, and exercise capacity in postmenopausal women. Sixty-four depressed postmenopausal women with associated sexual dysfunction were equally assigned to either a BEs group, which received diaphragmatic BEs, or a non-exercising control group. Both groups received individualized antidepressants and vaginal lubricants. Depressive symptoms were assessed using the Beck Depression Inventory-II (BDI-II), sexual function using the Female Sexual Function Index (FSFI), and exercise capacity using the six-minute walk test (6MWT) at baseline and after 12 weeks. At the end of the study, the BEs group showed significantly greater reductions in BDI-II scores (mean difference = − 4.22; 95% CI, − 6.19 to − 2.24; p = 0.001) and significantly greater increases in FSFI scores (mean difference = 5.01; 95% CI, 3.21 to 6.79; p = 0.001) compared with the control group with clinically significant differences for both measures. However, the between-group difference in 6MWT distance was not significant (mean difference = 28.28 m; 95% CI, − 2 to 58.57; p = 0.06). BEs could be an effective therapeutic intervention for managing depression and sexual dysfunction in this population of postmenopausal women, while no significant effect was observed on exercise capacity.",
            "content": "Alblooshi, S., Taylor, M. & Gill, N. Does menopause elevate the risk for developing depression and anxiety? Results from a systematic review. Australas Psychiatry. 31, 165–173. https://doi.org/10.1177/10398562231165439 (2023).\nFausto, D. Y., Martins,... [12875 chars]",
            "url": "https://www.nature.com/articles/s41598-026-41198-8?error=cookies_not_supported&code=6497bc04-d794-479d-a675-ed5730b20c0f",
            "image": "https://www.nature.com/static/images/favicons/nature/favicon-48x48-b52890008c.png",
            "publishedAt": "2026-02-23T06:00:00Z",
            "lang": "en",
            "source": {
                "id": "7abf0df285fbe93cdccffcc7c4088737",
                "name": "Nature",
                "url": "https://www.nature.com"
            }
        }
    ]
}